Ovid Therapeutics Inc.
OVID
$2.42
$0.062.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 3.23% | 34.12% | -11.78% | -28.34% | 50.72% |
| Total Depreciation and Amortization | -72.98% | -55.46% | -29.85% | -0.18% | 10.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.38% | 43.01% | 110.13% | 108.99% | -2,109.97% |
| Change in Net Operating Assets | -263.41% | -2,636.00% | -216.85% | -183.92% | -68.67% |
| Cash from Operations | 15.33% | 31.49% | 34.44% | 24.26% | 1.60% |
| Capital Expenditure | -- | -- | 64.52% | 75.00% | -15.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -223.88% | -191.20% | 387.24% | 295.80% | 414.54% |
| Cash from Investing | -224.04% | -191.32% | 385.92% | 295.00% | 413.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 39,656.76% | 11,991.16% | -95.73% | -93.94% | -41.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 40,238.08% | 11,991.16% | -99.91% | -99.83% | -98.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -133.33% |
| Net Change in Cash | 856.83% | -1,676.76% | 113.19% | 96.95% | 70.15% |